Hormone therapy linked to lower non-Hodgkin lymphoma risk — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/04/140407164602.htm
source : http://www.sciencedaily.com/releases/2014/04/140407164602.htm
source : http://www.sciencedaily.com/releases/2014/03/140325113236.htm
source : http://www.sciencedaily.com/releases/2014/03/140317084843.htm
source : http://www.sciencedaily.com/releases/2014/02/140224140441.htm
source : http://www.sciencedaily.com/releases/2014/02/140214111107.htm
source : http://www.sciencedaily.com/releases/2014/02/140203163439.htm
source : http://www.sciencedaily.com/releases/2014/01/140129164646.htm
The study, published in the journal Cancer, is the first to document this finding in a large population-based group, as well as the first to suggest IMRT could improve outcomes in head and neck cancer patients. …
The authors used a standard definition of overdiagnosis to refer to a cancer that would not have become symptomatic or clinically identifiable if it had not been detected by screening. Overdiagnosed cancers do not pose a risk to the patient and do not require treatment, which is associated with significant risks of impotence and incontinence. …
In the United States, uterine cancer is the fourth most common cancer in women, with an estimated 49,560 women diagnosed in 2013. In addition to surgery, 38 percent of patients undergo pelvic radiation therapy to decrease uterine cancer recurrence…